Incidence of imipenem-resistant Acinetobacter baumannii in a general intensive care unit (ICU)

Authors

Majid Mokhtari 2. Department of Critical Care Medicine, Emam Hossein Medical and Educational Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Mehran Kouchek 2. Department of Critical Care Medicine, Emam Hossein Medical and Educational Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Mehrdad Solouki 4. Department of Internal and Critical Care Medicine, Emam Hossein Medical and Educational Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Mirmohammad Miri 2. Department of Critical Care Medicine, Emam Hossein Medical and Educational Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Mohammad Sistanzad 3. Department of Clinical Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Mostafa Alavi-Moghadam 1. Department of Emergency Medicine, Emam Hossein Medical and Educational Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Reza Goharani 2. Department of Critical Care Medicine, Emam Hossein Medical and Educational Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Saeed Safari 1. Department of Emergency Medicine, Emam Hossein Medical and Educational Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Abstract:

Incidence of imipenem-resistant Acinetobacter baumannii in a general intensive care unit (ICU)

Upgrade to premium to download articles

Already have an account?login

similar resources

incidence of imipenem-resistant acinetobacter baumannii in a general intensive care unit (icu)

full text

Carbapenem-resistant Acinetobacter baumannii contamination in an intensive care unit.

INTRODUCTION: Acinetobacter baumannii is a major pathogen causing infections in intensive care units (ICUs). In this study, we aimed to evaluate the presence of A. baumannii in an ICU environment and gloves from ICU workers and to characterize the antimicrobial resistance of the isolates in comparison with those isolated from ICU patients at the same hospital. METHODS: ICU samples were collec...

full text

emergence of tigecycline resistant acinetobacter baumannii from an intensive care unit (icu) in tehran

conclusions it is clear that new antimicrobials are needed to treat mdr a. baumannii. polymyxins and tigecycline are among the fewrnantibiotics available to treat infections with these bacteria but little was known about the antimicrobial activity of these agents. thernpresent study provided valuable information about the effects of the above mentioned drugs that can be used for health policy. ...

full text

Multidrug-resistant Acinetobacter baumannii infection in the intensive care unit

provided the original work is properly cited. CC We read the report entitled “Multidrug-resistant Acinetobacter baumannii infection in intensive care unit patients in a hospital with building construction: is there an association?” [1] with great interest. In this report, Kamalbeik et al. [1] concluded that “further research is necessary to establish a relationship between A. baumannii and soil...

full text

A gloves-associated outbreak of imipenem-resistant Acinetobacter baumannii in an intensive care unit in Guangdong, China

BACKGROUND Imipenem-resistant Acinetobacter baumannii (IRAB) is an important cause of hospital-acquired infection. We aimed to describe an outbreak of IRAB infection and to investigate its possible source in an intensive care unit. METHODS An environmental investigation was undertaken. Antimicrobial susceptibility testing was performed by microdilution. These isolates were genotyped by use of...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}

Journal title

Caspian Journal of Internal Medicine

volume 5 issue None

pages 186- 187

publication date 2014-05

unfollow

{@ msg @}

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

Hosted on Doprax cloud platform doprax.com